Alector, Inc. Restructuring Charges
Alector, Inc. (ALEC) reported Restructuring Charges of $400.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-06
- Alector, Inc. restructuring charges for the quarter ending 2026-06-30 was $700.00K.
- Alector, Inc. restructuring charges for the quarter ending 2026-03-31 was -$300.00K, a 113.04% decline year-over-year.
- Alector, Inc. restructuring charges for the quarter ending 2025-12-31 was $100.00K.
- Alector, Inc. restructuring charges for the quarter ending 2025-09-30 was -$100.00K.
- Alector, Inc. restructuring charges for fiscal 2025 was $2.30M, a 41.03% decline from fiscal 2024.
- Alector, Inc. restructuring charges for fiscal 2024 was $3.90M, a 129.41% increase from fiscal 2023.
- Alector, Inc. restructuring charges for fiscal 2023 was $1.70M.
| Period end | Restructuring Charges | Restructuring Charges as first filed | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $400.00K 10-Q · filed 2026-08-06 | $500.00K derived: sum of 3 quarters · filed 2026-08-06 | $400.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$300.00K 10-Q · filed 2026-05-07 | -$200.00K derived: sum of 2 quarters · filed 2026-05-07 | -$300.00K derived: sum of 3 quarters · filed 2026-05-07 | -$300.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $2.30M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | -$100.00K 10-Q · filed 2025-11-06 | -$100.00K derived: sum of 2 quarters · filed 2025-11-06 | $2.20M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $2.30M 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | $2.30M 10-Q · filed 2026-05-07 | |||||
| 2025-03-07 | $2.30M 10-Q · filed 2025-11-06 | $2.40M 10-Q · filed 2025-05-08 | ||||
| 2024-12-31 | $3.90M 10-K · filed 2026-02-25 | |||||
| 2023-12-31 | $1.70M 10-K · filed 2025-02-26 | |||||
| 2023-03-29 | $1.70M 10-Q · filed 2023-11-07 | $2.10M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |